No 04 2019

Women in Life Science Denmark (WiLD) has announced the launch of WiLD Finland.

The aim of the initiative is to strengthen research in rare diseases where access to data and analytical tools remains limited.

Diamyd Medical is taking the next step in a long-term manufacturing collaboration with APL and, in parallel, is initiating a strategic collaboration with NorthX Biologics to further develop and scale the manufacturing of retogatein (rhGAD65) ahead of commercialization.

Recognized for transforming Swedish scientific excellence into global medical impact and for serving as a bold guiding star in building commercial capacity toward global markets, Hansa Biopharma, won the SwedenBIO Award 2025.

Life Science Invest’s sixth co-investment company, LSI Zeta, has raised EUR 2.9 million from 35 Nordic business angels.

The World Economic Forum's Top 10 Emerging Technologies of 2025 report explores the technologies that are set to have a significant impact on our lives, here are the ones with life science applications.

Lithuanian company Biomatter is an enzyme design company that bridges the gap between generative AI and real-world industrial applications.